The by now all-too-familiar vertiginous lines were intended to leave the public in no doubt about the consequences of not delaying freedom until July 19.
But take a closer look and the choice of graphs is arguably disingenuous: the slides are most revealing for what they failed to include.
Dr. Peter McCullough has been the world’s most prominent and vocal advocate for early outpatient treatment of SARS-CoV-2 (COVID-19) infection in order to prevent hospitalization and death. On May 19, 2021, I interviewed him about his efforts as a treating physician and researcher. From his unique vantage point, he has observed and documented a profoundly disturbing policy response to the pandemic—a policy response that may prove to be the greatest malpractice and malfeasance in the history of medicine and public health.”
Link to interview audio format released by Julian Charles of The Mind Renewed podcast.
I had no choice but to speak out against lockdowns. As a public-health scientist with decades of experience working on infectious-disease outbreaks, I couldn’t stay silent. Not when basic principles of public health are thrown out of the window. Not when the working class is thrown under the bus. Not when lockdown opponents were thrown to the wolves. There was never a scientific consensus for lockdowns. That balloon had to be popped.
…Ultimately, lockdowns protected young low-risk professionals working from home – journalists, lawyers, scientists, and bankers – on the backs of children, the working class and the poor.
Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published today (Thursday) as a Research letter in The Lancet.
The results also show that levels of these antibodies are lower with increasing age and that levels decline over time, providing additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the Autumn.
In the case of single-dose recipients, our data show that NAbTs are significantly lower against B.1.617.2 and B.1.351 VOCs relative to B.1.1.7, implying that although a single dose might still afford considerably more protection than no vaccination, single-dose recipients are likely to be less protected against these SARS-CoV-2 variants. These data therefore suggest that the benefits of delaying the second dose, in terms of wider population coverage and increased individual NAbTs after the second dose,7 must now be weighed against decreased efficacy in the short-term, in the context of the spread of B.1.617.2. Worldwide, our data highlight the ongoing need to increase vaccine supply to allow all countries to extend second-dose protection as quickly as possible.
In the longer term, we note that both increased age and time since the second dose of BNT162b2 significantly correlate with decreased NAb activity against B.1.617.2 and B.1.351—both of which are also characteristic of the population in the UK at highest risk of severe COVID-19 (ie, older and vaccinated earlier), independent of other existing factors such as compromised immune status or comorbidity, or geographic-specific responses to vaccination.
All under-40s are to be offered an alternative to the Oxford-AstraZeneca coronavirus vaccine as a precaution.
Dr. Sucharit Bhakdi, a Thai-German microbiologist, discusses mRNA vaccines, blood clots and Cerebral Venous Thrombosis. He warned about the vaccine side-effects months before the roll-out and appears to have been proven correct.
Rob Verkerk, Founder, Executive and Scientific Director of the Alliance for Natural Health International, a scientist who has for 30 years been exploring positive ways to span the gulfs between science and the law, between academia and industry, and between governments and their people.
Johnson & Johnson (J&J) has expanded Phase IIa clinical trial of Covid-19 vaccine candidate to include adolescent subjects aged 12 to 17 years.
“Those errors are when introducing people of more than one hundred years, it has happened that they are figurative as that those deceased have 1 year, or 2, or 3 instead of 101, 102 or 103 “, considers one of them,” Pere Soler, pediatrician of the Infectious Pathology and Pediatric Immunodeficiencies unit of the Vall d’Hebron hospital explains.
One year on from the start of the first lockdown, the brutal price of this drastic policy is all too obvious. Amid battered public finances, rising unemployment and widespread business failures, entire sectors of the economy have been devastated.
…Indeed, the average age of Covid fatalities is over 82, higher than the UK’s average age of death from all causes. And among those who contract the disease, just two in 1,000 (or fewer) actually die.
…But, while every death is a tragedy for bereaved families, 7 per cent above average does not strike me as a particularly shocking figure, especially since some of those deaths were caused by lockdowns themselves.
…In fact, there is no authoritative research that reveals a clear correlation between the severity of lockdowns and the avoidance of viral peaks.
Adults who lived with children during the pandemic’s second wave were only slightly more at risk of Covid-19 than those who lived without them, suggesting school attendance has minimal impact on infection rates, a new study has found.
While there was a small increased risk of infection and hospitalisation for those aged 65 and under who lived with school-aged children between September and December last year, they were no more likely to be admitted to intensive care or die than those who lived without children.
The peer-reviewed study, published in the British Medical Journal, found no evidence of a noticeably increased risk of infection during the first wave in the UK between February and August, compared to those adults who do not live with children.
Germany has recommended the AstraZeneca coronavirus vaccine should only be given to people under the age of 65, according to reports.
The country’s vaccine committee has reportedly said the jab, developed alongside the University of Oxford, should only be offered to people aged between 18 and 64.
It gave a lack of sufficient data on the effectiveness of the inoculation in older people as the reason for the decision in a draft recommendation.
Analysis of the age profile of Covid infections, however, does not point to schools being especially important in the early-stage growth of the second wave. Although the report does also observe that ‘school closures can contribute to a reduction in SARS-CoV-2 transmission’.
But had schools played a big role you would expect to have seen a sharp increase in cases among children of school age a week or two following the return to the classroom. Instead, the ECDC noted that Europe’s second wave began with a sharp increase in cases among 19 to 39 year olds in mid August. Cases among 16 to 18 year olds also increased around this time, but the curve of infections among younger children rose much more gradually, in step with infection rates in the over-40s.
The low seroprevalence of SARS-CoV-2 antibodies in young children in this study may indicate that they do not play a key role in SARS-CoV-2 spreading during the current pandemic.
- German researchers enrolled nearly 2,500 parents and their children in a study
- Found three times as many adults had coronavirus antibodies than children
- Data also shows a previously infected adult and an uninfected child was 4.3 times more common than a previously infected child and an uninfected parent
Children are unlikely to have played a significant role in the spread of coronavirus during the first wave last year, a study shows.
Throughout the pandemic it has become increasingly evident children are less affected by Covid-19; symptoms, severe disease and death figures in children are all much lower than would be expected when compared to the rest of the population.
Figures from Public Health England (PHE) show the current risk of dying from coronavirus if infected is 1,513 per 100,000 people for over-80s, but for children aged five to nine, this is just 0.1 per 100,000.
Ivor Cummins aka the Fat Emperor – gives James the lowdown on why you can’t trust anything our governments tell us about Covid-19. If you want the facts on Coronavirus – how deadly is it? do lockdowns and masks work? how does it compare with previous pandemics? – you’ve come to the right place
Please support the Delingpod:
Mirror archives are available below if this video is removed from YouTube.
Almost three times as many under 60s died in road crashes last year as those without health conditions killed by coronavirus, NHS data shows.
Just 388 people under the age of 60 with no underlying health conditions have died of coronavirus in England, NHS data has revealed.
ONLY 388 people aged under 60 without underlying health conditions have died of coronavirus in hospitals across England, NHS data shows.
The figure is just 0.8 per cent of all Covid fatalities recorded in English hospitals between April 2 and December 23.